4.6 Review

Control of Lymphocyte Fate, Infection, and Tumor Immunity by TCF-1

Journal

TRENDS IN IMMUNOLOGY
Volume 40, Issue 12, Pages 1149-1162

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.it.2019.10.006

Keywords

-

Categories

Funding

  1. Priority-Driven Collaborative Cancer Research Scheme
  2. Cancer Australia
  3. Cure Cancer Australia Foundation [1123388]
  4. Victorian Cancer Agency
  5. NIH [AI112579, AI121080, AI139874]
  6. Veteran Affairs BLRAMP
  7. D Merit Review Program [BX002903]

Ask authors/readers for more resources

T cell factor-1 (TCF-1), encoded by Tcf7, is a transcription factor and histone deacetylase (HDAC) essential for commitment to both the T cell and the innate lymphoid cell (ILC) lineages in mammals. In this review, we discuss the multifunctional role of TCF-1 in establishing these lineages and the requirement for TCF-1 throughout lineage differentiation and maintenance of lineage stability. We highlight recent reports showing promise for TCF-1 as a novel biomarker to identify recently characterized subsets of exhausted CD8(+) T cells that may help to predict patient responses to immune checkpoint blockade (ICB).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available